Literature DB >> 10358227

Unusual genetic heterogeneity of Acinetobacter baumannii isolates in a university hospital in Italy.

P Villari1, L Iacuzio, E A Vozzella, U Bosco.   

Abstract

BACKGROUND: Acinetobacter baumannii has become an increasingly important nosocomial pathogen, particularly in intensive care units (ICUs). The aim of this investigation was to study the molecular epidemiology of A baumanii in a university hospital in Italy.
METHODS: All A baumanii isolates were collected and typed with phenotypic and genotypic methods during a 7-month period. A 1-year prospective surveillance of ICU-acquired infections was performed by using the National Nosocomial Infections Surveillance methodology.
RESULTS: A baumanni accounted for 28.4% of all infections and 46.7% of all pneumonia acquired in the ICU, with a nosocomial infection rate of 12.4% or 8 infections per 1000 patient-days. Risk factors for A baumannii acquisition in the ICU were mechanical ventilation and previous use of broad-spectrum antibiotics, whereas administration of carbapenems showed a significant protective effect. Pulsed-field gel electrophoresis of genomic Apa I digests identified at least 5 outbreaks in the ICU caused by 5 different clones, one replacing the other in a well-defined temporal order.
CONCLUSIONS: Whereas the sequential temporal cluster of epidemic clones in the ICU is intriguing and requires further research, the clear evidence of cross-contamination of A baumannii isolates involved with infections in the ICU demands extensive preventive efforts.

Entities:  

Mesh:

Year:  1999        PMID: 10358227     DOI: 10.1053/ic.1999.v27.a96961

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  9 in total

1.  Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007.

Authors:  Chao Qi; Michael Malczynski; Michelle Parker; Marc H Scheetz
Journal:  J Clin Microbiol       Date:  2008-01-23       Impact factor: 5.948

2.  Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong.

Authors:  E T Houang; Y W Chu; C M Leung; K Y Chu; J Berlau; K C Ng; A F Cheng
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

3.  Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2.

Authors:  Chia-Ni Lee; Tsai-Tien Tseng; Juey-Wen Lin; Yung-Chieh Fu; Shu-Fen Weng; Yi-Hsiung Tseng
Journal:  Appl Environ Microbiol       Date:  2011-08-05       Impact factor: 4.792

4.  Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance.

Authors:  Raffaele Zarrilli; Margherita Crispino; Maria Bagattini; Elena Barretta; Anna Di Popolo; Maria Triassi; Paolo Villari
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 5.  Acinetobacter infections: a growing threat for critically ill patients.

Authors:  M E Falagas; E A Karveli; I I Siempos; K Z Vardakas
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

6.  Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.

Authors:  Jesús Rodríguez-Baño; Lola García; Encarnación Ramírez; Luis Martínez-Martínez; Miguel A Muniain; Felipe Fernández-Cuenca; Margarita Beltrán; Juan Gálvez; Jose M Rodríguez; Carmen Velasco; Concepción Morillo; Federico Perez; Andrea Endimiani; Robert A Bonomo; Alvaro Pascual
Journal:  Am J Infect Control       Date:  2009-05-19       Impact factor: 2.918

7.  Acinetobacter baumannii infections in a surgical intensive care unit: predictors of multi-drug resistance.

Authors:  Stilianos Katsaragakis; Haridimos Markogiannakis; Konstantinos G Toutouzas; Panagiotis Drimousis; Andreas Larentzakis; Eleni-Maria Theodoraki; Dimitrios Theodorou
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

8.  ERIC-PCR Genotyping of Acinetobacter baumannii Isolated from Different Clinical Specimens.

Authors:  Reem Aljindan; Khaldoon Alsamman; Nasreldin Elhadi
Journal:  Saudi J Med Med Sci       Date:  2017-12-14

9.  Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates.

Authors:  Carla Fontana; Marco Favaro; Silvia Minelli; Maria Cristina Bossa; Gian Piero Testore; Francesca Leonardis; Silvia Natoli; Cartesio Favalli
Journal:  BMC Infect Dis       Date:  2008-06-08       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.